Divya Murthy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Divya Murthy has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Pankaj K. Singh
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
26 shared publications - Kuldeep S. Attri
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
21 shared publications - Ryan J. King
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
21 shared publications - Ravi Thakur
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA
20 shared publications - Chunbo He
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA
18 shared publications - Camila G. Pacheco
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska
17 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (9) , 1975
Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- 4 August 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (9) , 1975
Open AccessAuthor Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- Open Access
- 19 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 840
Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- 19 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 840
Open AccessAuthor Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
- Top Cited PapersOpen Access
- 1 March 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (4) , 613-627
Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.
- 1 March 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (4) , 613-627
Top Cited PapersOpen AccessCancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP–seq and RNA–seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated acetylation of SP1 at the lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2–SP1–SAT1 axis diminished the tumour burden in mouse models. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2–SP1–SAT1 axis.
- 17 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216724
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer
- 17 February 2024
- Published by Elsevier in Cancer Letters
- Vol. 587, 216724
CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 1 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S1 shows that PDAC cellsregulate NK cell function by altering vitamin B6 and Tryptophan metabolism.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 1 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S1 shows that PDAC cellsregulate NK cell function by altering vitamin B6 and Tryptophan metabolism.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S7 shows that VB6 supplementation in combination with IDO and One carbon metabolism inhibition attenuates tumor burden in PDAC mice.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 4 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S4 shows that inhibition of glycogenolysis blocks VB6-mediated increased NKs effector function.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 4 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S4 shows that inhibition of glycogenolysis blocks VB6-mediated increased NKs effector function.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 5 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S5 shows that VB6 regulates the mobilization of glycogen to promote glycolysis in NK cells upon acute stimulation with target cells.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 5 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S5 shows that VB6 regulates the mobilization of glycogen to promote glycolysis in NK cells upon acute stimulation with target cells.
- Open Access
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 6 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S6 shows that PDAC cells maintain high metabolic rate of VB6 to support one-carbon metabolism and promote cell proliferation.
- 12 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 6 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Supplementary Figure S6 shows that PDAC cells maintain high metabolic rate of VB6 to support one-carbon metabolism and promote cell proliferation.